Acta Neurologica Belgica

, Volume 114, Issue 2, pp 145–148

DVT and pulmonary embolism with stroke

Letter to the Editor
  • 181 Downloads

References

  1. 1.
    Lehmeyer S, Lindhoff-Last E (2011) New aspects of paradoxical embolism. Vasa 40:31–40PubMedCrossRefGoogle Scholar
  2. 2.
    Mattle HP, Meier B, Nedeltchev K (2010) Prevention of stroke in patients with patent foramen ovale. Int J Stroke 5:92–102PubMedCrossRefGoogle Scholar
  3. 3.
    Handke M, Harloff A, Bode C, Geibel A (2009) Patent foramen ovale and cryptogenic stroke: a matter of age? Semin Thromb Hemost 35:505–514PubMedCrossRefGoogle Scholar
  4. 4.
    Handke M, Harloff A, Olschewski M et al (2007) Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357:2262–2268PubMedCrossRefGoogle Scholar
  5. 5.
    Tanislav C, Puille M, Pabst W et al (2011) High frequency of silent pulmonary embolism in patients with cryptogenic stroke and patent foramen ovale. Stroke 42:822–824PubMedCrossRefGoogle Scholar
  6. 6.
    Weir NU (2008) An update on cardioembolic stroke. Postgrad Med J 84:133–142PubMedCrossRefGoogle Scholar
  7. 7.
    Arboix A, Alio J (2012) Acute cardioembolic cerebral infarction: answers to clinical questions. Curr Cardiol Rev 8:54–67PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Murtagh B, Smalling RW (2006) Cardioembolic stroke. Curr Atheroscler Rep 8:310–316PubMedCrossRefGoogle Scholar
  9. 9.
    Ferro JM (2003) Brain embolism: answers to practical questions. J Neurol 250:139–147PubMedCrossRefGoogle Scholar
  10. 10.
    Irwin B, Ray S (2012) Patent foramen ovale–assessment and treatment. Cardiovasc Ther 30:e128–e135PubMedCrossRefGoogle Scholar
  11. 11.
    Schneeweiss S, Gagne JJ, Patrick AR et al (2012) Comparative efficacy and safety of new anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 5:480–486PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    O’Dell KM, Igawa D, Hsin J (2012) New anticoagulants for atrial fibrillation: a review of clinical trials. Clin Ther 34:894–901PubMedCrossRefGoogle Scholar
  13. 13.
    Deedwania PC, Huang GW (2011) Role of emerging antithrombotic therapy in the prevention of cardioembolic complication in patients with atrial fibrillation. Am J Cardiovasc Drugs 11:265–275PubMedCrossRefGoogle Scholar
  14. 14.
    Miller CS, Grandi SM, Shimony A et al (2012) Meta-analysis of efficacy and safety of new anticoagulants versus warfarin in patients with atrial fibrillation. Am J Cardiol 110(3):453–460PubMedCrossRefGoogle Scholar
  15. 15.
    Furlan AJ, Reisman M, Massarom J et al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991–999PubMedCrossRefGoogle Scholar
  16. 16.
    Carroll JD, Saver JL, Thaler DE et al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092–1100PubMedCrossRefGoogle Scholar

Copyright information

© Belgian Neurological Society 2013

Authors and Affiliations

  1. 1.Neurosciences Intensive Care Unit, Department of Critical Care and Emergency MedicineUniversity of Florida College of Medicine, JacksonvilleJacksonvilleUSA

Personalised recommendations